Summary
Pharmaceuticals in Mexico industry profile provides top-line qualitative and quantitative summary information including: market size (value 2016-20, and forecast to 2025). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The Mexican pharmaceuticals market had total revenues of $4.8bn in 2020, representing a compound annual growth rate (CAGR) of 1.1% between 2016 and 2020.
- In recent years, the Mexican Ministry of Health has been undertaking the task of improving the quality and affordability of pharmaceutical products through the promotion of generic substitutes. In Mexico, generic drugs are estimated to cost an average of 28% less than branded products, which could negatively impact the value of the market.
- Demographic factors such as an ageing population, poor diets, and sedentary job roles are stimulating demand for pharmaceutical products. This could help to keep growth in the market positive, albeit at a very slow rate.
Scope
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in Mexico
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Mexico
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Mexico pharmaceuticals market with five year forecasts
Reasons to Buy
- What was the size of the Mexico pharmaceuticals market by value in 2020?
- What will be the size of the Mexico pharmaceuticals market in 2025?
- What factors are affecting the strength of competition in the Mexico pharmaceuticals market?
- How has the market performed over the last five years?
- What are the main segments that make up Mexico's pharmaceuticals market?
'
Table of Contents
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
4 Market Segmentation
4.1. Geography segmentation
5 Market Outlook
5.1. Market value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Market share
7.2. Who are the leading players?
7.3. What strategies do leading players follow?
7.4. How does government regulation affect leading players?
8 Company Profiles
8.1. Bayer AG
8.2. Pfizer Inc.
8.3. Merck & Co., Inc.
8.4. Novartis AG
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
List of Tables
Table 1: Mexico pharmaceuticals market value: $ billion, 2016-20
Table 2: Mexico pharmaceuticals market geography segmentation: $ billion, 2020
Table 3: Mexico pharmaceuticals market value forecast: $ billion, 2020-25
Table 4: Mexico pharmaceuticals market share: % share, by value, 2020
Table 5: Bayer AG: key facts
Table 6: Bayer AG: Annual Financial Ratios
Table 7: Bayer AG: Key Employees
Table 8: Bayer AG: Key Employees Continued
Table 9: Pfizer Inc.: key facts
Table 10: Pfizer Inc.: Annual Financial Ratios
Table 11: Pfizer Inc.: Key Employees
Table 12: Pfizer Inc.: Key Employees Continued
Table 13: Merck & Co., Inc.: key facts
Table 14: Merck & Co., Inc.: Annual Financial Ratios
Table 15: Merck & Co., Inc.: Key Employees
Table 16: Merck & Co., Inc.: Key Employees Continued
Table 17: Novartis AG: key facts
Table 18: Novartis AG: Annual Financial Ratios
Table 19: Novartis AG: Key Employees
Table 20: Novartis AG: Key Employees Continued
Table 21: Mexico size of population (million), 2016-20
Table 22: Mexico gdp (constant 2005 prices, $ billion), 2016-20
Table 23: Mexico gdp (current prices, $ billion), 2016-20
Table 24: Mexico inflation, 2016-20
Table 25: Mexico consumer price index (absolute), 2016-20
Table 26: Mexico exchange rate, 2016-20
List of Figures
Figure 1: Mexico pharmaceuticals market value: $ billion, 2016-20
Figure 2: Mexico pharmaceuticals market geography segmentation: % share, by value, 2020
Figure 3: Mexico pharmaceuticals market value forecast: $ billion, 2020-25
Figure 4: Forces driving competition in the pharmaceuticals market in Mexico, 2020
Figure 5: Drivers of buyer power in the pharmaceuticals market in Mexico, 2020
Figure 6: Drivers of supplier power in the pharmaceuticals market in Mexico, 2020
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Mexico, 2020
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Mexico, 2020
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Mexico, 2020
Figure 10: Mexico pharmaceuticals market share: % share, by value, 2020
